← All stocks

Jaguar Health, Inc.

JAGX Net selling
CIK 0001585608 #5476 in the set updated 17 Sep 2026
Bought (120 mo)
$511.57K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$596.65K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$596.65K
3 of 3 sales
Net
−$85.08K
−$85.08K against sales at will

By person

13 insiders · 14 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Nantucket Investments Ltd entity
10% owner
$595.88K (1)
−$595.88K
0
$0.00
−100.0%
BOCHNOWSKI JAMES J
Director
$411.16K (2)
$775.48 (2)
+$410.39K
985,968
$29.58K
+62.0%
Siegel Jonathan B.
Director
$58.73K (5)
+$58.73K
20,699
$620.97
CONTE LISA A
See Remarks
$21.67K (2)
+$21.67K
29,258
$877.74
Lizak Carol R.
Chief Financial Officer
$20.00K (1)
+$20.00K
19,879
$596.37
Wolin Jonathan S.
See Remarks
$9.51 (1)
+$9.51
11,938
$358.14
Ezralow Bryan
Former 10% Owner
1,666,667
$50.00K
0.0%
GLASER JONATHAN M
Former 10% Owner
852,453
$25.57K
−6.6%
Divis Gregory J
Director
12,133
$363.99
Chaturvedi Pravin R
Chief Scientific Officer
11,938
$358.14
King Steven R.
See Remarks
11,885
$356.55
MICEK JOHN
Director
7,430
$222.90
Jayasuriya Anula
Director
5,916
$177.48

No percentages here. This company's share count has moved by a factor of 84.5 over the window, from 17,904 to 1,513,178 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Wolin Jonathan S.
31 Dec 2022
Chief of Staff, CCO & GC
Buy
317
$0.03
$9.51
CONTE LISA A
13 Sep 2021
CEO and President
Buy
7,968
$2.51
$20.00K
Lizak Carol R.
13 Sep 2021
Chief Financial Officer
Buy indirect
7,968
$2.51
$20.00K
BOCHNOWSKI JAMES J
23 Jul 2019
Director
Buy indirect
180,582
$2.00
$361.16K
Siegel Jonathan B.
23 Jul 2019
Director
Buy indirect
12,705
$2.00
$25.41K
Siegel Jonathan B.
4 Oct 2018
Director
Buy indirect
25,000
$0.60
$15.00K
CONTE LISA A
18 Jul 2018
CEO and President
Buy
1,500
$1.11
$1.67K
Siegel Jonathan B.
18 Jul 2018
Director
Buy indirect
5,000
$1.10
$5.48K
Siegel Jonathan B.
17 Jul 2018
Director
Buy indirect
2,232
$1.19
$2.66K
Siegel Jonathan B.
16 Jul 2018
Director
Buy indirect
7,500
$1.36
$10.19K
BOCHNOWSKI JAMES J
28 Jun 2017
Director
Buy indirect
100,000
$0.50
$50.00K

What was left out

Form 4 filings counted 162
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 1,706,741
Sales filed before the plan box existed 3
History held since 23 Sep 2016